Synapse - Connie Batlevi

Results (176)

Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting

Journal Article

Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
Cancers (2023)

Fulltext@MSK | Save

Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: An open label phase II study

Research Letter

Qualls, D.; Noy, A.; Straus, D.; Matasar, M.; Moskowitz, C.; Seshan, V.; Dogan, A.; Salles, G.; Younes, A.; Zelenetz, A. D.; more...
Leukemia and Lymphoma (2023)

Fulltext@MSK | Save

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Journal Article

Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
Leukemia (2023)

Fulltext@MSK | Save

MSK-ACCESS Heme: A cell-free DNA next-generation sequencing assay to identify somatic alterations in patients with lymphoma

Meeting Abstract

DiNapoli, S. E.; Spence, C.; Gedvilaite, E.; Bowman, A.; Diosdado, M.; Razumova, A.; Tsui, D.; Salles, G. A.; Batlevi, C.; von Keudell, G.; more...
Cancer Research (2022)

Fulltext@MSK | Save

Severe persistent cytopenias following CAR T-cell therapy in patients with large B-cell lymphoma

Meeting Abstract

De Lapuerta, M. C.; Shouval, R.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Batlevi, C. L.; Fein, J. A.; Giralt, S. A.; Lin, R. J.; Nath, K.; more...
Blood (2022)

Fulltext@MSK | Save

Enitociclib (VIP152/formerly BAY1251152) is a selective and active CDK9 inhibitor : Preliminary safety and early signs of efficacy in patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL)

Meeting Abstract

Shadman, M.; Mato, A. R.; Batlevi, C. L.; Flinn, I. W.; Gutierrez, M.; Uemura, M.; Stevens, D. A.; Morillo, D.; Byrd, J. C.; Frigault, M. M.; more...
Blood (2022)

Fulltext@MSK | Save

Characterization of a large cohort of patients with nodal marginal zone lymphoma shows prolonged survival, time-to-treatment, and time-to-transformation

Meeting Abstract

Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; more...
Blood (2022)

Fulltext@MSK | Save

Molecular profiling across lymphoma subtypes using MSK-impact next generation sequencing

Meeting Abstract

Batlevi, C. L.; Drill, E.; Okwali, M.; Ptashkin, R.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
Blood (2022)

Fulltext@MSK | Save

Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma